We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results:1-10 of 249

Federal Court Dismisses CFAA Claims Against Former Executive, Allows CFAA and DTSA Claims Against Competitor in Pharmaceuticals Trade Secret Dispute
  • Seyfarth Shaw LLP
  • USA
  • April 18 2018

A recent decision from the Eastern District of Pennsylvania reinforces the importance of the timing of purported misconduct in alleged violations of


Support growing for request that FDA freeze biosimilar applications
  • Shook Hardy & Bacon LLP
  • USA
  • February 21 2013

The Washington Legal Foundation (WLF), a public interest law and policy center, has filed comments with the U.S. Food and Drug Administration (FDA)


Product makers and sellers beware: the use of unlawful software or hardware by a product manufacturer is now an act of unfair competition in Washington state
  • Hogan Lovells
  • USA
  • July 21 2011

On 22 June 2011, it became an act of unfair competition in Washington state for product manufacturers whose products are offered for sale in Washington state to use "stolen or misappropriated IT" in their business operations.


Increased risks to disclosure of proprietary information and trade secrets presented by new California environmental legislation
  • Alston & Bird LLP
  • USA
  • October 18 2010

Product design and manufacture used to be functions that a company could conduct internally, and in so doing, protect valuable proprietary processes and trade secret information from public disclosure.




Adam R. Steinert
  • Fredrikson & Byron PA